These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Polaneczky M, Guarnaccia M, Alon J, Wiley J. Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283 [Abstract] [Full Text] [Related]
7. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M. Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [Abstract] [Full Text] [Related]
11. Effect of medroxyprogesterone acetate contraception on human serum enzymes. Mukherjea M, Mukherjee P, Biswas R, Chakraborty AS, Kushari J. Int J Fertil; 1981 Jan; 26(1):35-9. PubMed ID: 6113206 [Abstract] [Full Text] [Related]
12. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM. J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705 [Abstract] [Full Text] [Related]
13. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception. Nelson AL. J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701 [Abstract] [Full Text] [Related]
14. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct]. Kremer J, de Bruijn HW, Hindriks FR. Ned Tijdschr Geneeskd; 1981 Aug 25; 125(35):1418-21. PubMed ID: 6456421 [Abstract] [Full Text] [Related]
15. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. Kaunitz AM. Int J Fertil Womens Med; 1998 Aug 25; 43(2):73-83. PubMed ID: 9609206 [Abstract] [Full Text] [Related]
16. Characteristics of injectable contraceptive users in a low-income population in Texas. Sangi-Haghpeykar H, Poindexter AN, Moseley DC, Bateman L, Reid ED. Fam Plann Perspect; 1995 Aug 25; 27(5):208-11, 225. PubMed ID: 9104608 [Abstract] [Full Text] [Related]
17. A case-control study of breast cancer and hormonal contraception in Costa Rica. Lee NC, Rosero-Bixby L, Oberle MW, Grimaldo C, Whatley AS, Rovira EZ. J Natl Cancer Inst; 1987 Dec 25; 79(6):1247-54. PubMed ID: 2961909 [Abstract] [Full Text] [Related]
18. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women. Amatayakul K, Sivassomboon B, Singkamani R. Contraception; 1980 Mar 25; 21(3):283-97. PubMed ID: 6446443 [Abstract] [Full Text] [Related]
19. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Contraception; 2009 Dec 25; 80(6):519-26. PubMed ID: 19913145 [Abstract] [Full Text] [Related]
20. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis]. Zhou J, Lei ZW, Lü JQ, Sun J, Xu XW. Zhonghua Fu Chan Ke Za Zhi; 2005 Jan 25; 40(1):5-8. PubMed ID: 15774083 [Abstract] [Full Text] [Related] Page: [Next] [New Search]